1. Home
  2. APRE vs EDUC Comparison

APRE vs EDUC Comparison

Compare APRE & EDUC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Logo Educational Development Corporation

EDUC

Educational Development Corporation

HOLD

Current Price

$1.45

Market Cap

12.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
APRE
EDUC
Founded
2006
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Consumer Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
12.3M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
APRE
EDUC
Price
$0.76
$1.45
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
186.4K
57.6K
Earning Date
05-13-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
21.22
142.86
EPS
N/A
0.27
Revenue
N/A
$22,913,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.41
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$1.01
52 Week High
$2.22
$1.84

Technical Indicators

Market Signals
Indicator
APRE
EDUC
Relative Strength Index (RSI) 41.36 55.58
Support Level $0.75 $1.26
Resistance Level $0.81 $1.50
Average True Range (ATR) 0.08 0.07
MACD -0.01 -0.00
Stochastic Oscillator 10.98 65.26

Price Performance

Historical Comparison
APRE
EDUC

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

About EDUC Educational Development Corporation

Educational Development Corp distributes books and educational products and publications through its PaperPie and EDC Publishing divisions to individual consumers, book, toy and gift stores, libraries and home educators located throughout the United States. The company is the owner and exclusive publisher of Kane Miller children's books; Learning Wrap-Ups, maker of educational manipulatives; and SmartLab Toys, maker of STEAM-based toys and games. It also the exclusive United States Multi-Level Marketing (MLM) distributor of Usborne Publishing Limited (Usborne) children's books. It sell children's books, educational toys and games and other related products. It has two reportable segments: PaperPie and Publishing of which majority of revenue comes from Paperpie.

Share on Social Networks: